ARC Clinical research is looking for healthy females ages 16-40 for a new research study.
ARC Clinical Research is part of Moderna's CMVictory Trial to evaluate the safety and efficacy of an investigational mRNA vaccine to protect against cytomegalovirus (CMV) infection. CMV is a common virus that can have serious consequences for pregnant women or people with weak immune systems. CMV is the number one infectious cause of birth defects in the U.S.
Learn more. CMVictory.com or Get more information and request to participate.